A Phase 1 Open-label Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates for CYP1A2 and CYP2D6 in Male Subjects with Prostate Cancer
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A study to evaluate how daily dosing with enzalutamide affects the metabolism of caffeine and dextromethorphan in men with prostate cancer? Contact us by filling our your information to the right and we’ll respond to you.
Chisinau, Republic of Moldova, 2025